169 related articles for article (PubMed ID: 37432852)
21. Development of extrahepatic bile ducts and mechanisms of tumorigenesis: Lessons from mouse models.
Tomita H; Hara A
Pathol Int; 2022 Dec; 72(12):589-605. PubMed ID: 36349994
[TBL] [Abstract][Full Text] [Related]
22. [A case report of cholangiectasis with cholangiocarcinoma].
Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
Bickenbach K; Galka E; Roggin KK
Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
[TBL] [Abstract][Full Text] [Related]
24. [Establishment and application of intrahepatic cholangiocarcinoma organoid models].
Liu Y; Liang X
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):346-352. PubMed ID: 38432677
[TBL] [Abstract][Full Text] [Related]
25. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
27. Intraductal papillary neoplasm of the bile duct: A rare precursor of cholangiocarcinoma.
Verset L; Lucidi V; Demetter P
Liver Int; 2019 Apr; 39(4):777-778. PubMed ID: 30549408
[No Abstract] [Full Text] [Related]
28. Intrahepatic cholangiocarcinoma: a worthy challenge.
Bartlett DL
Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
[No Abstract] [Full Text] [Related]
29. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
30. Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.
Nishimura M; Naka S; Hanazawa K; Tani T; Fukami M; Okada S; Fujiyama Y
Dig Dis Sci; 2005 Nov; 50(11):2153-8. PubMed ID: 16240231
[No Abstract] [Full Text] [Related]
31. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
[TBL] [Abstract][Full Text] [Related]
32. Cholangiocarcinoma development: the resurgence of bile acids.
Maroni L; Alpini G; Marzioni M
Hepatology; 2014 Sep; 60(3):795-7. PubMed ID: 24828905
[No Abstract] [Full Text] [Related]
33. Prospective study of biliary cytology in suspected perihilar cholangiocarcinoma.
Hattori M; Nagino M; Ebata T; Kato K; Okada K; Shimoyama Y
Br J Surg; 2011 May; 98(5):704-9. PubMed ID: 21290384
[TBL] [Abstract][Full Text] [Related]
34. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.
Saito Y; Nakaoka T; Muramatsu T; Ojima H; Sukeda A; Sugiyama Y; Uchida R; Furukawa R; Kitahara A; Sato T; Kanai Y; Saito H
Sci Rep; 2018 Feb; 8(1):2821. PubMed ID: 29434290
[TBL] [Abstract][Full Text] [Related]
35. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinoma: preventing invasion as anti-cancer strategy.
Gores GJ
J Hepatol; 2003 May; 38(5):671-3. PubMed ID: 12713880
[No Abstract] [Full Text] [Related]
37. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges.
Liu Y; Yeh MM
Hum Pathol; 2023 Feb; 132():158-168. PubMed ID: 35714833
[TBL] [Abstract][Full Text] [Related]
38. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation.
Goto N; Yasuda I; Uematsu T; Kanemura N; Takao S; Ando K; Kato T; Osada S; Takao H; Saji S; Shimokawa K; Moriwaki H
J Gastroenterol; 2001 Dec; 36(12):856-62. PubMed ID: 11777216
[TBL] [Abstract][Full Text] [Related]
40. Extrahepatic cholangiocarcinoma: current surgical strategy.
Boutros C; Somasundar P; Espat NJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
